Cramer: This ‘Cannabis’ Stock Will Quickly Double

CNBC’s Jim Cramer strongly endorsed an analyst’s bullish call on GW Pharma (GWPH) in his “Stop Trading” segment on CNBC’s “Squawk on the Street.” “It’s not a medical marijuana stock. They have a novel platform. It is an epilepsy company.”